Literature DB >> 630038

The estimation of false negatives in medical screening.

J D Goldberg, J T Wittes.   

Abstract

In a medical screening program for early detection of disease, one or more screening modes are administered to an apparently healthy population. Knowledge of the true disease status for all screened individuals would allow estimation of the false negative and false positive rates for each mode of detection and for the program as a whole. This paper develops capture-recapture methods applicable to programs as a whole. This paper develops capture-recapture methods applicable to programs when follow-up of individuals negative on screening is not performed or is incomplete. The methods require at least two independent modes of detection. Data from a breast cancer screening program illustrate the procedure. The results of four screening examinations at approximately one-year intervals and the long-term follow-up of all screened individuals support the usefulness of these methods in the evaluation of a screening program.

Entities:  

Mesh:

Year:  1978        PMID: 630038

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  5 in total

1.  Chapter 9: options for summarizing medical test performance in the absence of a "gold standard".

Authors:  Thomas A Trikalinos; Cynthia M Balion
Journal:  J Gen Intern Med       Date:  2012-06       Impact factor: 5.128

2.  Voluntary and involuntary capture-recapture samples--problems in the estimation of hidden and elusive populations.

Authors:  R Neugebauer; J Wittes
Journal:  Am J Public Health       Date:  1994-07       Impact factor: 9.308

3.  Efficiencies of liquid-liquid extraction, carbon, and XAD-2 absorption in isolating organic compounds from environmental sources.

Authors:  K G Janardan; D J Schaeffer; S M Somani
Journal:  Bull Environ Contam Toxicol       Date:  1980-01       Impact factor: 2.151

4.  Estimating the sensitivity of breast cancer screening--experience with the Honolulu BCDDP data.

Authors:  J S Grove; M J Goodman; F I Gilbert; G Low
Journal:  Breast Cancer Res Treat       Date:  1991-05       Impact factor: 4.872

5.  Use of screening tests to assess cancer risk and to estimate the risk of adult T-cell leukemia/lymphoma.

Authors:  T Yanagawa; S Tokudome
Journal:  Environ Health Perspect       Date:  1990-07       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.